Erasca, Inc.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 20, 2025
ERAS$15.48-0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of stockholders’ equity
(In thousands, except share data)
| Accumulated | ||||||
|---|---|---|---|---|---|---|
| Additional · Other · Total | ||||||
| Common Stock · Paid-in · Comprehensive · Accumulated · Stockholders' | ||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Equity | |
| Balance at December 31, 2022 | 150,448,363 | $15 | $893,850 | $(1,041) | $(480,971) | $411,853 |
| Exercise of stock options | 624,807 | — | 505 | — | — | 505 |
| Issuance of common stock under the Employee Stock Purchase Plan | 388,933 | — | 790 | — | — | 790 |
| Vesting of early exercised stock options | — | — | 1,231 | — | — | 1,231 |
| Stock-based compensation expense | — | — | 26,231 | — | — | 26,231 |
| Net loss | — | — | — | — | (125,042) | (125,042) |
| Unrealized gain on marketable securities, net | — | — | — | 1,118 | — | 1,118 |
| Balance at December 31, 2023 | 151,462,103 | $15 | $922,607 | $77 | $(606,013) | $316,686 |
| Issuance of common stock in private placement, net of $1,396 in fees and expenses | 21,844,660 | 2 | 43,602 | — | — | 43,604 |
| Issuance of common stock in underwritten offering, net of $9,574 in discounts and offering costs | 99,459,458 | 10 | 174,416 | — | — | 174,426 |
| Issuance of common stock in ATM Offering, net of $847 in commissions and expenses | 9,231,114 | 1 | 21,030 | — | — | 21,031 |
| Exercise of stock options | 710,280 | — | 836 | — | — | 836 |
| Issuance of common stock under the Employee Stock Purchase Plan | 510,729 | — | 800 | — | — | 800 |
| Vesting of early exercised stock options | — | — | 465 | — | — | 465 |
| Stock-based compensation expense | — | — | 26,973 | — | — | 26,973 |
| Net loss | — | — | — | — | (161,650) | (161,650) |
| Unrealized gain on marketable securities, net | — | — | — | 328 | — | 328 |
| Balance at December 31, 2024 | 283,218,344 | $28 | $1,190,729 | $405 | $(767,663) | $423,499 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.